JP2007522094A5 - - Google Patents

Download PDF

Info

Publication number
JP2007522094A5
JP2007522094A5 JP2006527154A JP2006527154A JP2007522094A5 JP 2007522094 A5 JP2007522094 A5 JP 2007522094A5 JP 2006527154 A JP2006527154 A JP 2006527154A JP 2006527154 A JP2006527154 A JP 2006527154A JP 2007522094 A5 JP2007522094 A5 JP 2007522094A5
Authority
JP
Japan
Prior art keywords
kinase
drug
hexokinase
complex
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2006527154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007522094A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/031147 external-priority patent/WO2005030258A2/en
Publication of JP2007522094A publication Critical patent/JP2007522094A/ja
Publication of JP2007522094A5 publication Critical patent/JP2007522094A5/ja
Abandoned legal-status Critical Current

Links

JP2006527154A 2003-09-22 2004-09-22 小分子組成物、及びその組成物を使用して薬物効率を高めるための方法 Abandoned JP2007522094A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50532503P 2003-09-22 2003-09-22
US58183504P 2004-06-22 2004-06-22
PCT/US2004/031147 WO2005030258A2 (en) 2003-09-22 2004-09-22 Small molecule compositions and methods for increasing drug efficiency using compositions thereof

Publications (2)

Publication Number Publication Date
JP2007522094A JP2007522094A (ja) 2007-08-09
JP2007522094A5 true JP2007522094A5 (cg-RX-API-DMAC7.html) 2007-12-06

Family

ID=34396244

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006527154A Abandoned JP2007522094A (ja) 2003-09-22 2004-09-22 小分子組成物、及びその組成物を使用して薬物効率を高めるための方法

Country Status (5)

Country Link
EP (1) EP1689439A2 (cg-RX-API-DMAC7.html)
JP (1) JP2007522094A (cg-RX-API-DMAC7.html)
AU (1) AU2004275770A1 (cg-RX-API-DMAC7.html)
CA (1) CA2539914A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005030258A2 (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
PL359169A1 (en) 2000-05-26 2004-08-23 Idenix (Cayman) Limited Methods and compositions for treating flaviviruses and pestiviruses
KR20050035194A (ko) 2002-06-28 2005-04-15 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
AU2003298658A1 (en) 2002-11-15 2004-06-15 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
US7598373B2 (en) 2002-12-12 2009-10-06 Idenix Pharmaceuticals, Inc. Process for the production of 2-C-methyl-D-ribonolactone
WO2007076160A2 (en) * 2005-12-28 2007-07-05 Acidophil Llc C-10 carbamates of taxanes
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
JP5542804B2 (ja) 2008-05-23 2014-07-09 ザ ユニヴァーシティ オブ ブリティッシュ コロンビア リポソームナノ粒子中で使用するための修飾薬物
DK2318832T3 (da) 2008-07-15 2014-01-20 Academia Sinica Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
US9556216B2 (en) 2012-08-31 2017-01-31 Novartis Ag 2′-Ethynyl nucleoside derivatives for treatment of viral infections
JP2016501200A (ja) 2012-11-19 2016-01-18 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. ウイルス性疾患を処置するための2−アルキニル置換ヌクレオシド誘導体
WO2014210397A1 (en) 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
EP3013347B1 (en) * 2013-06-27 2019-12-11 Academia Sinica Glycan conjugates and use thereof
EP3041484B1 (en) 2013-09-06 2021-03-03 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
KR20160104727A (ko) 2014-01-16 2016-09-05 아카데미아 시니카 암의 치료 및 검출을 위한 조성물 및 방법
TWI797430B (zh) 2014-03-27 2023-04-01 中央研究院 反應性標記化合物及其用途
KR20170010003A (ko) 2014-05-27 2017-01-25 아카데미아 시니카 박테로이드 기원의 푸코시다제 및 이의 사용 방법
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
EP4116329A1 (en) 2014-05-27 2023-01-11 Academia Sinica Anti-her2 glycoantibodies and uses thereof
JP2017518989A (ja) 2014-05-27 2017-07-13 アカデミア シニカAcademia Sinica 抗cd20糖操作抗体群およびその使用
JP7063538B2 (ja) 2014-05-28 2022-05-09 アカデミア シニカ 抗TNFα糖操作抗体群およびその使用
EP3191500A4 (en) 2014-09-08 2018-04-11 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
AU2015378564A1 (en) 2015-01-24 2017-07-13 Academia Sinica Novel glycan conjugates and methods of use thereof
CN109195996A (zh) 2016-03-08 2019-01-11 中央研究院 N-聚醣及其阵列的模组化合成方法
CA3034057A1 (en) 2016-08-22 2018-03-01 CHO Pharma Inc. Antibodies, binding fragments, and methods of use
CN112368293A (zh) 2018-05-15 2021-02-12 英特肽治疗有限公司 活化剂
JP7386852B2 (ja) * 2018-05-15 2023-11-27 インテルク ペプチド セラピューティクス リミテッド ペプチド活性化剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59083A (en) * 1979-01-10 1983-12-30 Israel Marcus Pharmaceutical composition containing thymidine and a salicyclic acid derivative as a solubilizing agent therefor
US5608049A (en) * 1995-03-10 1997-03-04 Bristol-Myers Squibb Company Preparation of d4T from 5-methyluridine
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds

Similar Documents

Publication Publication Date Title
JP2007169302A5 (cg-RX-API-DMAC7.html)
JP2007302683A5 (cg-RX-API-DMAC7.html)
JP2004516265A5 (cg-RX-API-DMAC7.html)
JP2003503454A5 (cg-RX-API-DMAC7.html)
NO20053245D0 (no) Tabletter med modifisert frigjoring av bupropionhydroklorid.
DE602004017510D1 (de) Medizinprodukt vom kapseltyp
JP2009524695A5 (cg-RX-API-DMAC7.html)
MA28489B1 (fr) Preparations pharmaceutiques
NO332405B1 (no) Forbindelse av 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling, deres anvendelse til fremstilling av farmasoytiske midler for behandling av inflammatorisk sykdom og farmasoytisk preparat omfattende forbindelsen.
CL2007003690A1 (es) Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas.
WO2005030258A3 (en) Small molecule compositions and methods for increasing drug efficiency using compositions thereof
FR2910473B1 (fr) Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
WO2007144169A3 (en) Entacapone-derivatives
WO2008006795A3 (en) Indole compounds
WO2006095029A3 (en) Di-polymer protein conjugates and processes for their preparation
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
FR2873690B1 (fr) Derives d'oxopiperidine, leur preparation et leur application en therapeutique
PT1718340E (pt) Novos conjugados de efectores, processo para a sua produção e sua utilização farmacêutica
JP2008519810A5 (cg-RX-API-DMAC7.html)
JP2005508892A5 (cg-RX-API-DMAC7.html)
FR2912404B1 (fr) Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
JP2006527741A5 (cg-RX-API-DMAC7.html)
WO2007144699A3 (en) Process for the preparation of alfuzosin
Kolata For a world of woes, we blame cookie monsters
ATE489943T1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate